综合医院GeneXpert MTB/RIF检测支气管肺泡灌洗液极低结核分枝杆菌诊断肺结核的准确性

doi:10.19982/j.issn.1000-6621.20240062

中国防痨杂志 ›› 2024, Vol. 46 ›› Issue (9): 1037-1041.doi: 10.19982/j.issn.1000-6621.20240062

综合医院GeneXpert MTB/RIF检测支气管肺泡灌洗液极低结核分枝杆菌诊断肺结核的准确性

梅春林, 杨澄清(), 杜荣辉, 曹探赜, 冯伟, 陈淑芳, 刘修平, 欧佳莉

武汉市肺科医院呼吸与危重症医学科,武汉 430030

收稿日期:2024-02-18 出版日期:2024-09-10 发布日期:2024-08-30
通信作者: 杨澄清,Email:147391593@qq.com
基金资助:
湖北省卫生健康科研项目(WJ2019H320);武汉医学中青年骨干人才培养工程(201987);武汉市肺科医院院内科研项目(YNZZ202209)

Diagnostic accuracy of GeneXpert MTB/RIF in detecting pulmonary tuberculosis with extremely low loads of MTB in bronchoalveolar lavage fluid in general hospitals

Mei Chunlin, Yang Chengqing(), Du Ronghui, Cao Tanze, Feng Wei, Chen Shufang, Liu Xiuping, Ou Jiali

Department of Respiratory and Critical Medicine, Wuhan Pulmonary Hospital, Wuhan 430030, China

Received:2024-02-18 Online:2024-09-10 Published:2024-08-30
Contact: Yang Chengqing, Email: 147391593@qq.com
Supported by:
Health Commission of Hubei Province Scientific Research Project(WJ2019H320);Wuhan Medical Young Talent Training Project(201987);The Funds of Wuhan Pulmonary Hospital(YNZZ202209)

摘要/Abstract

摘要：

目的: 评价武汉市综合医院行支气管肺泡灌洗液GeneXpert MTB/RIF(简称“BALF-Xpert”)检出极低(Ct值>28)结核分枝杆菌(MTB)诊断肺结核的准确性。方法: 采用前瞻性研究方法,参照入组标准顺序纳入2019年1月1日至2022年12月30日武汉市肺科医院呼吸与危重症医学科收治的来自12家综合医院以BALF-Xpert检出MTB极低诊断的肺结核患者为研究对象。统计并分析所有入组患者复查BALF-Xpert、抗酸杆菌涂片镜检、分枝杆菌培养、TB-RNA和TB-DNA的检测结果,并最终经3名以上副主任医师综合进行临床诊断,且随访至少1年,以评估综合医院BALF-Xpert检出极低MTB诊断肺结核的准确性。结果: 共纳入67例患者,经BALF-Xpert复查,发现MTB检出率为38.81%(26/67),其中MTB极低、低、中和高拷贝量分别为20例(76.92%)、5例(19.23%)、1例(3.85%)和0例。而且,BALF-Xpert检测阳性率分别高于涂片[4.48%(3/67)]和TB-RNA[17.91%(12/67)],差异均有统计学意义(χ²=23.280,P=0.001;χ²=7.200,P=0.007);但与培养[29.85%(20/67)]和TB-DNA[25.37%(17/67)]检测阳性率差异均无统计学意义(χ²=1.192,P=0.275;χ²=2.774,P=0.096)。联合5种检测方法的总阳性率为40.30%(27/67)。最终诊断为肺结核43例,非肺结核24例,误诊率高达35.82%。结论: 以BALF-Xpert检出极低MTB诊断肺结核存在较高假阳性率,需结合患者临床表现、影像学表现、结核感染免疫学结果进行综合诊断,必要时需复查。

关键词: 医院,综合, 核酸扩增技术, 结核,肺, 诊断, 误诊

Abstract:

Objective: To evaluate the accuracy of diagnosing pulmonary tuberculosis (PTB) with extremely low loads of Mycobacterium tuberculosis (MTB) (Ct value >28) in bronchoalveolar lavage fluid by GeneXpert MTB/RIF (BALF-Xpert) in Wuhan general hospitals. Methods: A prospective study was conducted on PTB patients admitted to the Department of Respiratory and Critical Care Medicine of Wuhan Pulmonary Hospital from January 1, 2019 to December 30, 2022, who were referred from 12 general hospitals with extremely low loads of MTB detected by BALF-Xpert. The results of retesting BALF-Xpert, acid-fast bacilli smear microscopy, mycobacterial culture, TB-RNA, and TB-DNA were analyzed. All patients were clinically diagnosed by 3 or more associate professors and followed up for at least 1 year to evaluate the accuracy of BALF-Xpert in detecting MTB with extremely low loads in general hospitals. Results: A total of 67 patients were included. After retesting with BALF-Xpert, 38.81% (26/67) were detected as MTB positive, including 20 cases (76.92%) with extremely low loads, 5 cases (19.23%) with low loads, 1 case (3.85%) with medium loads, and 0 case with high loads of MTB. The positive rate of BALF-Xpert was higher than that of smear microscopy (4.48% (3/67)) and TB-RNA (17.91% (12/67)), with statistically significant difference (χ²=23.280, P=0.001; χ²=7.200, P=0.007). There was no significant difference between BALF-Xpert and culture (29.85% (20/67)) and TB-DNA (25.37% (17/67))(χ²=1.192, P=0.275; χ²=2.774, P=0.096). The total positive rate of combining 5 diagnostic methods was 40.30% (27/67). Forty-three patients were finally diagnosed with tuberculosis and 24 patients were diagnosed as non-tuberculosis disease, with a misdiagnosis rate of 35.82%. Conclusion: BALF-Xpert has a high false positive rate for detection of PTB cases with extremely low loads MTB. A comprehensive diagnosis should be made based on the patient’s clinical manifestations, imaging findings, and immunological results for MTB infection and re-examination is recommended, if necessary.

Key words: Hospital, general, Nucleic acid amplification techniques, Tuberculosis, pulmonary, Diagnosis, Misdiagnosis

中图分类号:

R521

梅春林, 杨澄清, 杜荣辉, 曹探赜, 冯伟, 陈淑芳, 刘修平, 欧佳莉. 综合医院GeneXpert MTB/RIF检测支气管肺泡灌洗液极低结核分枝杆菌诊断肺结核的准确性[J]. 中国防痨杂志, 2024, 46(9): 1037-1041. doi: 10.19982/j.issn.1000-6621.20240062

Mei Chunlin, Yang Chengqing, Du Ronghui, Cao Tanze, Feng Wei, Chen Shufang, Liu Xiuping, Ou Jiali. Diagnostic accuracy of GeneXpert MTB/RIF in detecting pulmonary tuberculosis with extremely low loads of MTB in bronchoalveolar lavage fluid in general hospitals[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1037-1041. doi: 10.19982/j.issn.1000-6621.20240062

图/表 2

参考文献 16

[1]	World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
[2]	国家呼吸内科医疗质量控制中心, 中华医学会结核病学分会, 中国防痨协会结核病控制专业分会, 等. 综合医疗机构肺结核早期发现临床实践指南. 中国防痨杂志, 2024, 46(2): 127-140. doi:10.19982/j.issn.1000-6621.20230428.
[3]	阮云洲, 张红伟, 李月华, 等. 综合医院引入GeneXpert MTB/RIF技术早期发现病原学阳性和耐药肺结核患者的效果分析. 中国防痨杂志, 2023, 45(11): 1072-1077. doi:10.19982/j.issn.1000-6621.20230313.
[4]	杨澄清, 梅春林, 杜荣辉, 等. 分子生物学假阳性致肺癌性淋巴管炎误诊为肺结核的临床诊治过程分析. 中国防痨杂志, 2022, 44(3): 289-293. doi:10.19982/j.issn.1000-6621.20210561.
[5]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09.
[6]	World Health Organization. WHO operational handbook on tuberculosis. Module 3: Diagnosis-Rapid diagnostics for tuberculosis detection, 2021 update. Geneva: World Health Organization, 2021.
[7]	孙金昊, 陶磊, 贺向红, 等. GeneXpert MTB/RIF系统、MGIT-960快速培养系统及药敏检测肺结核患者痰标本、支气管肺泡灌洗液标本阳性率比较及耐药分析. 临床军医杂志, 2022, 50(12):1275-1277, 1281. doi:10.16680/j.1671-3826.2022.12.19.
[8]	Le Palud P, Cattoir V, Malbruny B, et al. Retrospective observational study of diagnostic accuracy of the XpertMTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. Bmc Pulm Med, 2014, 14:137. doi:10.1186/1471-2466-14-137.
[9]	Wang J, Zhang X, Huo F, et al. Analysis of Xpert MTB/RIF results in retested patients with very low initial bacterial loads: A retrospective study in China. J Infect Public Health, 2023, 16(6):911-916. doi:10.1016/j.jiph.2023.04.004.
[10]	Theron G, Venter R, Smith L, et al. False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes. J Clin Microbiol, 2018, 56(3):e01696-17. doi:10.1128/JCM.01696-17.
[11]	Theron G, Venter R, Calligaro G, et al. Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?. Clin Infect Dis, 2016, 62(8):995-1001. doi:10.1093/cid/civ1223. pmid: 26908793
[12]	中华医学会结核病学分会临床检验专业委员会. 结核病病原学分子诊断专家共识. 中华结核和呼吸杂志, 2018, 41(9): 688-695. doi:10.3760/cma.j.issn.1001-0939.2018.09.008.
[13]	Esmail H, Dodd PJ, Houben RMGJ. Tuberculosis transmission during the subclinical period: could unrelated cough play a part?. Lancet Respir Med, 2018, 6(4):244-246. doi:10.1016/S2213-2600(18)30105-X. pmid: 29595504
[14]	Pai M, Behr MA, Dowdy D, et al. Tuberculosis. Nat Rev Dis Primers, 2016, 2:16076. doi:10.1038/nrdp.2016.76. pmid: 27784885
[15]	Sarınoğlu RC, Duman N, Ünlü N, et al. Xpert MTB/Ultra assay: Handle with care. J Infect, 2020, 80(3):350-371. doi:10.1016/j.jinf.2019.11.009. pmid: 31733232
[16]	中华人民共和国国家卫生和计划生育委员会. WS 507—2016软式内镜清洗消毒技术规范. 2016-12-27.

Xpert检测	例数	涂片镜检		分枝杆菌培养		TB-DNA		TB-RNA		联合检测
Xpert检测	例数	阳性	阴性	阳性	阴性	阳性	阴性	阳性	阴性	阳性	阴性
MTB未检出	41(61.19)	0(0.00)	41(61.19)	1(1.49)	40(59.70)	0(0.00)	41(61.19)	0(0.00)	41(61.19)	1(1.49)	40(59.70)
MTB检出	26(38.81)	3(4.48)	23(34.33)	19(28.36)	7(10.45)	17(25.37)	9(13.43)	12(17.91)	14(20.90)	26(38.81)	0(0.00)
极低	20(29.85)	0(0.00)	20(29.85)	15(22.39)	5(7.46)	13(19.40)	7(10.45)	8(11.94)	12(17.91)	20(29.85)	0(0.00)
低	5(7.46)	2(2.99)	3(4.48)	3(4.48)	2(2.99)	3(4.48)	2(2.99)	3(4.48)	2(2.99)	5(7.46)	0(0.00)
中	1(1.49)	1(1.49)	0(0.00)	1(1.49)	0(0.00)	1(1.49)	0(0.00)	1(1.49)	0(0.00)	1(1.49)	0(0.00)
高	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)	0(0.00)

综合医院GeneXpert MTB/RIF检测支气管肺泡灌洗液极低结核分枝杆菌诊断肺结核的准确性

Diagnostic accuracy of GeneXpert MTB/RIF in detecting pulmonary tuberculosis with extremely low loads of MTB in bronchoalveolar lavage fluid in general hospitals

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 16

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	朱明智, 邵燕琴, 范大鹏, 刘立宾, 梅宾, 戴玲珊, 蔡龙. 尿液脂阿拉伯甘露聚糖抗原检测对肺外结核的诊断价值[J]. 中国防痨杂志, 2025, 47(4): 471-476.
[2]	罗莉, 罗林紫, 尹曲华, 周磊, 卢志斌, 丁衍, 肖阳宝. 淋巴结瘘型气管支气管结核的支气管镜下诊疗进展[J]. 中国防痨杂志, 2025, 47(4): 505-512.
[3]	中国人民解放军总医院第八医学中心结核病医学部, 《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会, 结核病防治分会基础和临床学部. 结核性腹膜炎多学科诊疗专家共识[J]. 中国防痨杂志, 2025, 47(3): 243-257.
[4]	段鸿飞, 陶勇. 《眼内结核诊断规范》团体标准解读[J]. 中国防痨杂志, 2025, 47(3): 258-261.
[5]	贾辉, 景辉, 凌晓洁, 王燕, 李学政. GeneXpert MTB/RIF Ultra检测痰液样本对新发肺结核的诊断价值[J]. 中国防痨杂志, 2025, 47(3): 298-304.
[6]	石玉如, 谷德健, 吴静, 刘婷, 秦令寒, 岳莉, 戚应杰. 靶向捕获测序技术和宏基因组二代测序技术检测肺泡灌洗液中结核分枝杆菌的诊断价值[J]. 中国防痨杂志, 2025, 47(3): 305-311.
[7]	杨子仪, 陈素婷. 贝达喹啉耐药及耐药诊断的研究进展[J]. 中国防痨杂志, 2025, 47(3): 374-379.
[8]	严广璇, 王雪钰, 王宇津, 兰汀隆, 聂文娟. 宏基因组二代测序对疑似骨关节结核患者的诊断价值[J]. 中国防痨杂志, 2025, 47(2): 175-180.
[9]	邱勇, 权卓, 屈榕, 田发君, 李蒙, 王更生, 王娅, 郭明成, 高谦. 县级实验室结核病检测方法的诊断效果分析: 一项基于真实世界数据的回顾性研究[J]. 中国防痨杂志, 2025, 47(2): 181-188.
[10]	赵悦, 王昊然, 程美锦, 王伟, 梁瑞霞, 黄海荣. 涂片阳性/Xpert阴性结果早期预测临床标本中存在非结核分枝杆菌的可靠性[J]. 中国防痨杂志, 2025, 47(1): 61-65.
[11]	解慧, 吴娇娇. 痰涂片结核分枝杆菌检查和抗原胶体金法检验应用于肺结核的价值[J]. 中国防痨杂志, 2024, 46(S2): 32-34.
[12]	朱元子, 焦荣红. 肿瘤标志物和细胞因子联合检测对早期肺腺癌的诊断价值[J]. 中国防痨杂志, 2024, 46(S2): 62-64.
[13]	张芃. γ-干扰素释放试验在肺结核诊断中的临床应用价值[J]. 中国防痨杂志, 2024, 46(S2): 74-75.
[14]	杨景云, 熊媛, 雷霖涵, 赵省婷, 苏艳, 徐根深, 王绍婷, 赵得荣. 磁共振增强T2 FLAIR序列在结核性脑膜炎中的诊断价值及疗效评估研究[J]. 中国防痨杂志, 2024, 46(S2): 86-87.
[15]	苗建来, 梁如钰. PCR在肺结核诊断中的应用研究[J]. 中国防痨杂志, 2024, 46(S2): 94-95.